China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)
China · Delayed Price · Currency is CNY 27.69
-0.49 (-1.74%)
Apr 9, 2026, 3:04 PM CST
SHE:000999 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 3,421 | 3,368 | 2,853 | 2,449 | 2,055 |
Depreciation & Amortization | 1,173 | 723.19 | 786.67 | 522.66 | 478.75 |
Other Amortization | 257.19 | 177.07 | 67.11 | 48.75 | 45.84 |
Loss (Gain) From Sale of Assets | -6.5 | -31.43 | -0.81 | -2.28 | -0.85 |
Asset Writedown & Restructuring Costs | 52.93 | 19.72 | 88.97 | 99.81 | 52.33 |
Loss (Gain) From Sale of Investments | -227.41 | -26.05 | 28.63 | -2.58 | -5.04 |
Provision & Write-off of Bad Debts | 36.53 | 82.87 | 55.04 | 5.53 | 13.63 |
Other Operating Activities | 878.45 | 595.17 | 467.94 | 102.6 | 200.43 |
Change in Accounts Receivable | 748.84 | -1,243 | 633.69 | -71.84 | -674.74 |
Change in Inventory | 385.96 | 67.83 | -966.01 | -59.69 | -652.26 |
Change in Accounts Payable | -1,154 | 682.7 | 315.29 | -21.86 | 458.43 |
Operating Cash Flow | 5,513 | 4,402 | 4,192 | 3,006 | 1,885 |
Operating Cash Flow Growth | 25.24% | 5.02% | 39.43% | 59.52% | -15.26% |
Capital Expenditures | -1,271 | -790.07 | -857.21 | -951.57 | -872.6 |
Sale of Property, Plant & Equipment | 8.03 | 5.17 | 26.43 | 1.78 | 4.56 |
Cash Acquisitions | -5,251 | - | 953.63 | -11.76 | -120.63 |
Divestitures | -5.24 | - | 4.25 | - | - |
Investment in Securities | -1,093 | -424.16 | -953.36 | -1,584 | -870.37 |
Other Investing Activities | 202.16 | 78.65 | 32.77 | 66.4 | 66.74 |
Investing Cash Flow | -7,410 | -1,130 | -793.5 | -2,479 | -1,792 |
Long-Term Debt Issued | 6,544 | 1,007 | 3,578 | 593.69 | 97.97 |
Total Debt Issued | 6,544 | 1,007 | 3,578 | 593.69 | 97.97 |
Short-Term Debt Repaid | -500 | -4.2 | -17.05 | -1.45 | -3.1 |
Long-Term Debt Repaid | -3,254 | -2,771 | -1,930 | -520.27 | -105.43 |
Total Debt Repaid | -3,754 | -2,775 | -1,947 | -521.72 | -108.53 |
Net Debt Issued (Repaid) | 2,790 | -1,768 | 1,631 | 71.98 | -10.56 |
Issuance of Common Stock | - | 10 | - | 150.6 | 10.18 |
Repurchase of Common Stock | -35.15 | -2.21 | - | - | - |
Common Dividends Paid | -1,256 | -2,834 | -1,056 | -855.78 | -505.66 |
Other Financing Activities | 64.52 | -33.92 | -124.98 | 57.75 | -162.98 |
Financing Cash Flow | 1,564 | -4,629 | 450.42 | -575.45 | -669.02 |
Foreign Exchange Rate Adjustments | -11.87 | 2.88 | 5.01 | 6.35 | -2.31 |
Net Cash Flow | -344.99 | -1,354 | 3,854 | -41.93 | -578.98 |
Free Cash Flow | 4,242 | 3,612 | 3,335 | 2,055 | 1,012 |
Free Cash Flow Growth | 17.43% | 8.33% | 62.28% | 103.03% | -36.83% |
Free Cash Flow Margin | 13.42% | 13.08% | 13.48% | 11.37% | 6.51% |
Free Cash Flow Per Share | 2.55 | 2.17 | 2.00 | 1.23 | 0.61 |
Cash Income Tax Paid | 3,293 | 2,701 | 2,762 | 1,839 | 1,919 |
Levered Free Cash Flow | -387.51 | 2,494 | 149.87 | 1,534 | 73.83 |
Unlevered Free Cash Flow | -313.99 | 2,544 | 200.36 | 1,547 | 82.7 |
Change in Working Capital | -72.39 | -506.25 | -154.74 | -216.92 | -955.53 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.